HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jorge Joven Selected Research

Aryldialkylphosphatase (Paraoxonase)

6/2022Effect of Low-Dose Radiotherapy on the Circulating Levels of Paraoxonase-1-Related Variables and Markers of Inflammation in Patients with COVID-19 Pneumonia.
2/2021Paraoxonase-1 and -3 Protein Expression in the Brain of the Tg2576 Mouse Model of Alzheimer's Disease.
2/2021Influence of Surgical Procedures on Serum Paraoxonase-1-Related Variables and Markers of Inflammation in Hospitalized Patients.
1/2021On the Role of Paraoxonase-1 and Chemokine Ligand 2 (C-C motif) in Metabolic Alterations Linked to Inflammation and Disease. A 2021 Update.
1/2021Identification of potential metabolic biomarkers of rectal cancer and of the effect of neoadjuvant radiochemotherapy.
10/2019Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and inflammation.
7/2019Serum Paraoxonase-1-Related Variables and Lipoprotein Profile in Patients with Lung or Head and Neck Cancer: Effect of Radiotherapy.
1/2019Chemokine (C-C motif) ligand 2 gene ablation protects low-density lipoprotein and paraoxonase-1 double deficient mice from liver injury, oxidative stress and inflammation.
11/2018Trace Elements and Paraoxonase-1 Activity in Lower Extremity Artery Disease.
11/2018Effect of continuous renal-replacement therapy on paraoxonase-1-related variables in patients with acute renal failure caused by septic shock.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jorge Joven Research Topics

Disease

47Neoplasms (Cancer)
12/2021 - 11/2010
40Inflammation (Inflammations)
06/2022 - 01/2005
22Atherosclerosis
03/2016 - 01/2004
17Obesity
01/2022 - 01/2010
17Fatty Liver
05/2021 - 01/2005
17Breast Neoplasms (Breast Cancer)
12/2019 - 11/2010
11Infections
01/2022 - 11/2005
10Non-alcoholic Fatty Liver Disease
01/2022 - 05/2010
10Liver Diseases (Liver Disease)
01/2021 - 12/2005
8Fibrosis (Cirrhosis)
01/2022 - 07/2006
8Insulin Resistance
01/2016 - 09/2005
8HIV Infections (HIV Infection)
01/2012 - 03/2006
6Carcinoma (Carcinomatosis)
06/2021 - 03/2012
6Cardiovascular Diseases (Cardiovascular Disease)
05/2019 - 03/2003
6Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2016 - 12/2009
5COVID-19
06/2022 - 06/2021
5Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 01/2002
5Hyperlipidemias (Hyperlipidemia)
05/2019 - 03/2003
5Type 2 Diabetes Mellitus (MODY)
01/2019 - 11/2010
4Virus Diseases (Viral Diseases)
01/2022 - 11/2005
4Neoplasm Metastasis (Metastasis)
06/2021 - 11/2010
4Lung Neoplasms (Lung Cancer)
06/2021 - 11/2013
4Alcoholic Fatty Liver
05/2021 - 01/2005
4Mitochondrial Diseases (Mitochondrial Disease)
05/2021 - 03/2015
4Chronic Disease (Chronic Diseases)
01/2018 - 09/2003
4Carcinogenesis
05/2014 - 11/2011
3Morbid Obesity
12/2021 - 01/2020
3Weight Loss (Weight Reduction)
12/2021 - 10/2017
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 10/2013
3Communicable Diseases (Infectious Diseases)
11/2018 - 01/2014
3Sepsis (Septicemia)
11/2018 - 02/2012
3Peripheral Arterial Disease
05/2017 - 12/2014
3Genomic Instability
03/2016 - 01/2014
3Arteriosclerosis
05/2010 - 02/2006
3Lipodystrophy
08/2006 - 09/2005
3Myocardial Infarction
06/2006 - 05/2002
3Carotid Artery Diseases
06/2006 - 11/2005
2Rectal Neoplasms (Rectal Cancer)
01/2021 - 05/2014
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2020 - 07/2019
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2020 - 11/2018

Drug/Important Bio-Agent (IBA)

36Aryldialkylphosphatase (Paraoxonase)IBA
06/2022 - 05/2002
26Metformin (Glucophage)FDA LinkGeneric
08/2021 - 09/2005
17Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2006
17Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2020 - 10/2004
15EnzymesIBA
06/2022 - 05/2002
14PolyphenolsIBA
10/2020 - 06/2011
12Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2002
12LipidsIBA
01/2022 - 01/2004
12ChemokinesIBA
01/2021 - 11/2005
11AntioxidantsIBA
06/2022 - 11/2005
11BiguanidesIBA
08/2021 - 11/2010
11Lipoproteins (Lipoprotein)IBA
01/2021 - 05/2002
11CholesterolIBA
10/2017 - 07/2004
11ApolipoproteinsIBA
03/2016 - 09/2002
9Pharmaceutical PreparationsIBA
01/2018 - 12/2011
8Glucose (Dextrose)FDA LinkGeneric
01/2019 - 09/2005
8Triglycerides (Triacylglycerol)IBA
10/2017 - 09/2002
6Biological ProductsIBA
01/2019 - 09/2007
5CytokinesIBA
04/2022 - 05/2010
5Silybin (Lagosa)IBA
06/2021 - 01/2013
5LigandsIBA
01/2021 - 11/2005
5Trastuzumab (Herceptin)FDA Link
01/2019 - 11/2010
5Olive OilIBA
01/2018 - 01/2005
5C-Reactive ProteinIBA
05/2017 - 01/2005
4IronIBA
12/2021 - 01/2004
4CC ChemokinesIBA
01/2020 - 01/2013
4Histones (Histone)IBA
12/2019 - 06/2011
4CarbonIBA
01/2019 - 07/2012
4HomocysteineIBA
01/2019 - 01/2002
4Insulin (Novolin)FDA Link
01/2016 - 09/2013
4Rosiglitazone (Avandia)FDA Link
03/2014 - 09/2005
4Fatty Acid Synthases (Fatty Acid Synthase)IBA
01/2013 - 01/2009
3Monoclonal AntibodiesIBA
01/2022 - 03/2012
3Trace Elements (Biometals)IBA
12/2021 - 07/2018
3AntibodiesIBA
11/2021 - 04/2007
3Galectin 3 (LGALS3)IBA
06/2021 - 05/2017
3HDL LipoproteinsIBA
02/2021 - 09/2007
3DNA (Deoxyribonucleic Acid)IBA
12/2019 - 03/2012
3Hormones (Hormone)IBA
01/2019 - 01/2014
3Folic Acid (Vitamin M)FDA LinkGeneric
01/2019 - 01/2008
3LDL Lipoproteins (beta Lipoproteins)IBA
01/2019 - 04/2007
3Chemokine ReceptorsIBA
12/2014 - 01/2013
3Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2013 - 06/2011
3MicroRNAs (MicroRNA)IBA
01/2013 - 03/2012
3Hypoglycemic Agents (Hypoglycemics)IBA
07/2012 - 03/2012
3Apolipoproteins E (ApoE)IBA
10/2010 - 01/2004
3Dietary CholesterolIBA
05/2010 - 12/2007
2Peptide Hydrolases (Proteases)FDA Link
01/2022 - 01/2014
2Matrix Metalloproteinases (MMPs)IBA
01/2022 - 01/2008
2Transferrin (beta 2 Transferrin)IBA
12/2021 - 03/2005
2NAD (NADH)IBA
08/2021 - 01/2014
2SilymarinIBA
06/2021 - 10/2013
2TOR Serine-Threonine KinasesIBA
05/2021 - 09/2013
2oxidized low density lipoproteinIBA
05/2019 - 04/2007

Therapy/Procedure

16Therapeutics
01/2020 - 09/2005
5Radiotherapy
06/2022 - 01/2017
4Bariatric Surgery
01/2022 - 06/2015
4Gastrectomy
12/2021 - 06/2015
4Drug Therapy (Chemotherapy)
11/2018 - 01/2014
3Neoadjuvant Therapy
12/2019 - 11/2018